EX-23.1 3 tm205262d1_ex23-1.htm EXHIBIT 23.1

 

 

 

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (file no. 333-221091), S-8 (on file no. 333-232353), S-3 (file no. 333-221093) and S-3 (file no. 333-219884) of Fennec Pharmaceuticals Inc. (the "Company") of our report dated February 14, 2020 relating to the consolidated financial statements as of December 31, 2019, which appear in the Annual Report on Form 10-K for the year ended December 31, 2019.

 

 

  /s/ HASKELL & WHITE LLP
   
  HASKELL & WHITE LLP

 

Irvine, California

February 14, 2020